Christopher A. Miller

Washington University in St. Louis — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

96h-index78.5kcitations551works5.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(177), Acute Myeloid Leukemia Research(152), Genetic factors in colorectal cancer(56), Lymphoma Diagnosis and Treatment(53), Immunotherapy and Immune Responses(32)

Publications465 total

ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.
PubMed·2025
Mechanisms of chemotherapy resistance driven by Mecom overexpression
Blood·2025Open Access
Persistent binding of DNMT1 to chromatin causes replication dysfunction in TP53-mutated myeloid neoplasms
Blood·2025Open Access
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid Cancers
Journal of Molecular Diagnostics·2025Open Access
63767 Most complications during the operative course for nasolabial interpolation flap surgery do not alter the chance of scar interventions
Journal of the American Academy of Dermatology·2025
63613 Smoking is associated with a 10-fold increased risk for necrosis of the nasolabial interpolation flap
Journal of the American Academy of Dermatology·2025
64519 Prophylactic Postoperative Antibiotics Do Not Reduce Wound Infection Rates after Nasolabial Interpolation Flap Surgery
Journal of the American Academy of Dermatology·2025
5-006 Individualised NT-proBNP thresholds for the diagnosis of heart failure
Heart failure·2025Open Access
Overexpression of the signaling coordinator GAB2 can play an important role in acute myeloid leukemia progression
Journal of Clinical Investigation·2025· 2 citedOpen Access
Prognostic impact of atrio-ventricular conduction abnormalities in non-ischemic cardiomyopathy
EP Europace·2025Open Access
pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection
Genome Medicine·2024· 7 citedOpen Access
Reduced <i>CBFB</i> Expression Causes Compensatory Upregulation of <i>RUNX1</i> Expression, Defining a Feedback Loop That May be Relevant for AML Pathogenesis
Blood·2024Open Access
VISTA As a Mediator of Immune Suppression in AML Initiated By <i>DNMT3A</i> and <i>NPM1</i> mutations
Blood·2024
Recurrent Amplification of Chromosome 7 in Murine AML with <i>Dnmt3a</i>R878H and <i>Npm1</i>cA Mutations Identifies <i>Gab2</i> As a Possible Therapeutic Target in AML
Blood·2024Open Access
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis
JAMA·2024· 101 citedOpen Access
Considerations for Drug Trials in Hypertrophic Cardiomyopathy
ESC Heart Failure·2024· 3 citedOpen Access
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response
Leukemia·2024
Oxygen-enhanced MRI versus PREFUL in assessing pulmonary ventilation in COPD and healthy individuals.
2024
76. Automating immunogenomic tumor board decision-making for neoantigen cancer vaccine design
Cancer Genetics·2024
11. Developing a robust bioinformatics workflow to support personalized neoantigen vaccine clinical trials
Cancer Genetics·2024
page 1 of 24Next →

Frequent Co-authors

Timothy J. Ley(27), Robert S. Fulton(27), Richard K. Wilson(25), Elaine R. Mardis(24), Matthew J. Walter(19), Li Ding(18), John F. DiPersio(18), Daniel C. Link(16), Timothy A. Graubert(15), John S. Welch(14), Peter Westervelt(14), Joshua F. McMichael(13), Sharon E. Heath(12), Catrina C. Fronick(12), David E. Larson(11), Michael D. McLellan(11), Charles Lu(10), Obi L. Griffith(10), Malachi Griffith(10), Michael C. Wendl(9)